- Home
- SOTK vs STTK Comparison
SOTK vs STTK Comparison
Compare SOTK & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- STTK
- Stock Information
- Founded
- SOTK 1975
- STTK 2016
- Country
- SOTK United States
- STTK United States
- Employees
- SOTK N/A
- STTK N/A
- Industry
- SOTK Industrial Machinery/Components
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- STTK Health Care
- Exchange
- SOTK Nasdaq
- STTK Nasdaq
- Market Cap
- SOTK 61.8M
- STTK 56.8M
- IPO Year
- SOTK 1987
- STTK 2020
- Fundamental
- Price
- SOTK $3.91
- STTK $1.18
- Analyst Decision
- SOTK Buy
- STTK Hold
- Analyst Count
- SOTK 1
- STTK 3
- Target Price
- SOTK $7.50
- STTK $2.00
- AVG Volume (30 Days)
- SOTK 31.9K
- STTK 160.7K
- Earning Date
- SOTK 01-13-2025
- STTK 02-27-2025
- Dividend Yield
- SOTK N/A
- STTK N/A
- EPS Growth
- SOTK N/A
- STTK N/A
- EPS
- SOTK 0.07
- STTK N/A
- Revenue
- SOTK $20,151,145.00
- STTK $6,435,000.00
- Revenue This Year
- SOTK $6.11
- STTK $313.04
- Revenue Next Year
- SOTK $9.27
- STTK N/A
- P/E Ratio
- SOTK $57.01
- STTK N/A
- Revenue Growth
- SOTK 8.40
- STTK 382.75
- 52 Week Low
- SOTK $3.50
- STTK $0.94
- 52 Week High
- SOTK $6.07
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- SOTK 44.52
- STTK 48.53
- Support Level
- SOTK $3.71
- STTK $1.06
- Resistance Level
- SOTK $4.59
- STTK $1.21
- Average True Range (ATR)
- SOTK 0.44
- STTK 0.09
- MACD
- SOTK -0.01
- STTK -0.00
- Stochastic Oscillator
- SOTK 18.65
- STTK 31.82
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.